Galderma Group revenue and financials

GALD · SIX · CHF

Compare Galderma Group
CHF 187.15Change from previous close: −2.02%Absolute change: −CHF 3.85

Close · November 17, 2026

In the fiscal year ended December 2025, Galderma Group reported revenue of $5.24B (+18.04% year over year). Net income was $613M, a net margin of 11.7%.

Annual revenue · 2025: $5.24B
  1. $3.45B2021
  2. $3.82B2022
  3. $4.12B2023
  4. $4.44B2024
  5. $5.24B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+18.04%
2025 vs 2024
Net income growth
+165.37%
2025 vs 2024
Net margin
11.7%
2024: 5.2%

How Galderma Group is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue5,2414,4404,1173,8243,445
Cost of revenue1,6321,3551,2321,1941,034
Gross profit3,6093,0852,8852,6302,411
Selling, general and administrative2,4902,1511,9901,9081,711
Research and development245260287316343
Operating income885671606401350
EBIT885671606401350
EBITDA1,134891818630567
Interest expense173352561398353
Pre-tax income63931011.0-51.9-79.6
Income tax26.079.068.045.04.6
Net income613231-57.0-98.5-154
Net income to common shareholders613231-57.0-98.5-154
Basic EPS2.600.97-0.24-0.02-0.03
Diluted EPS2.580.97-0.24-0.02-0.03
Average shares (basic)2362382385,1885,188
Average shares (diluted)2372382385,1885,188
Dividend per share0.440.17———

Companies in the group: same industry, similar size